CIK: 0001907884 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 14, 2025
Total Value ($000): $1,343,111 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CLDX | CELLDEX THERAPEUTICS INC NEW | 6,100,729 | $157,826 | 11.8% | $29.50 | -21.5% | COM NEW | 15117B202 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 8,520,000 | $131,080 | 9.8% | $17.75 | -26.2% | COM | 87164F105 |
| VERA | VERA THERAPEUTICS INC | 4,027,800 | $117,048 | 8.7% | $21.50 | +7.6% | CL A | 92337R101 |
| COGT | COGENT BIOSCIENCES INC | 7,886,172 | $113,245 | 8.4% | $7.97 | +48.7% | COM | 19240Q201 |
| PCVX | VAXCYTE INC | 3,071,588 | $110,639 | 8.2% | $77.50 | -57.3% | COM | 92243G108 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 4,427,927 | $95,555 | 7.1% | $16.74 | +7.8% | COM | 92790C104 |
| CGON | CG ONCOLOGY INC | 2,005,205 | $80,770 | 6.0% | $34.56 | -15.9% | COM | 156944100 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 9,390,270 | $71,272 | 5.3% | $6.82 | +22.0% | COM | 09058V103 |
| BEAM | BEAM THERAPEUTICS INC | 2,517,647 | $61,103 | 4.5% | $25.65 | -22.4% | COM | 07373V105 |
| IMCR | IMMUNOCORE HLDGS PLC | 1,009,267 | $36,667 | 2.7% | $29.77 | — | ADS | 45258D105 |
| MBX | MBX BIOSCIENCES INC | 2,000,000 | $35,000 | 2.6% | $13.37 | 0.0% | COM | 55287L101 |
| ENGN | ENGENE HOLDINGS INC | 4,994,090 | $34,110 | 2.5% | $7.65 | -40.4% | COM | 29286M105 |
| WVE | WAVE LIFE SCIENCES LTD | 4,560,053 | $33,380 | 2.5% | $4.64 | +74.4% | SHS | Y95308105 |
| TYRA | TYRA BIOSCIENCES INC | 2,329,998 | $32,597 | 2.4% | $13.36 | -14.7% | COM | 90240B106 |
| TVTX | TRAVERE THERAPEUTICS INC | 949,727 | $22,698 | 1.7% | $15.29 | +22.9% | COM | 89422G107 |
| — | DYNAVAX TECHNOLOGIES CORP | 2,145,319 | $21,303 | 1.6% | $12.15 | — | COM NEW | 268158201 |
| NRIX | NURIX THERAPEUTICS INC | 2,168,605 | $20,038 | 1.5% | $12.80 | -18.8% | COM | 67080M103 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 67,588 | $20,010 | 1.5% | $336.31 | 0.0% | COM | 91307C102 |
| APLS | APELLIS PHARMACEUTICALS INC | 808,607 | $18,299 | 1.4% | $23.32 | 0.0% | COM | 03753U106 |
| PHVS | PHARVARIS N V | 675,000 | $16,841 | 1.3% | $22.18 | 0.0% | COM | N69605108 |
| RLAY | RELAY THERAPEUTICS INC | 2,887,014 | $15,070 | 1.1% | $4.42 | -13.6% | COM | 75943R102 |
| CGEM | CULLINAN THERAPEUTICS INC | 2,302,172 | $13,652 | 1.0% | $11.72 | -37.5% | COM | 230031106 |
| CTMX | CYTOMX THERAPEUTICS INC | 3,646,503 | $11,632 | 0.9% | $1.87 | +20.2% | COM | 23284F105 |
| AMRN | AMARIN CORP PLC | 576,111 | $9,437 | 0.7% | $16.22 | — | SPONSORED ADR | 023111404 |
| BNR | BURNING ROCK BIOTECH LTD | 994,883 | $8,606 | 0.6% | $6.40 | — | SPONSORED ADS | 12233L206 |
| DSGN | DESIGN THERAPEUTICS INC | 1,029,579 | $7,753 | 0.6% | $4.65 | +7.8% | COM | 25056L103 |
| KALV | KALVISTA PHARMACEUTICALS INC | 606,171 | $7,383 | 0.5% | $13.82 | 0.0% | COM | 483497103 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 5,466,825 | $7,162 | 0.5% | $6.46 | -84.0% | COM CL A | 46333X108 |
| CRBU | CARIBOU BIOSCIENCES INC | 3,067,774 | $7,148 | 0.5% | $3.41 | -44.7% | COM | 142038108 |
| URGN | UROGEN PHARMA LTD | 282,412 | $6,936 | 0.5% | $9.64 | +86.4% | COM | M96088105 |
| GERN | GERON CORP | 3,456,318 | $4,735 | 0.4% | $2.44 | -45.3% | COM | 374163103 |
| — | SUTRO BIOPHARMA INC | 5,088,099 | $4,419 | 0.3% | $2.71 | — | COM | 869367102 |
| EWTX | EDGEWISE THERAPEUTICS INC | 253,979 | $4,120 | 0.3% | $14.42 | -1.6% | COM | 28036F105 |
| PRQR | PROQR THRAPEUTICS N V | 1,649,462 | $3,513 | 0.3% | $3.18 | -31.2% | SHS EURO | N71542109 |
| CLYM | CLIMB BIO INC | 1,028,341 | $2,067 | 0.2% | $2.66 | -30.3% | COM | 28658R106 |